Rebecca Guzman is a corporate transactional partner at Duane Morris. She focuses on the
representation of start-up and emerging growth companies with a focus on life science companies in
the biotechnology, pharmaceutical, medical device, diagnostics and healthcare IT industries. Her
practice spans the entire corporate lifecycle, from formation through liquidity. In addition to her
company client counsel, Rebecca represents a number of prominent venture capital funds and
institutional investors in their financing activities. Rebecca is broadly experienced in M&A and
currently serves as a vice chair of the M&A Division of the firm. Resident in Duane Morris’ Delaware
office, she also has extensive experience and regularly advises in all areas of Delaware corporate
and alternative entity law. Rebecca was named to Best of the Bar by the Philadelphia Business
Journal in 2022 and recently named a Most Effective Deal Maker by the Legal Intelligencer.
